MedTrace Logo

Evaluation of Cetaphil Advanced Usage to Control Light to Moderate Atopic Dermatitis, in Attempt to Reduce the Necessity of Topic Corticoids Application

NCT01063218 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 74

Last updated 2012-03-12

No results posted yet for this study

Summary

The main goal of this present study is evaluate the decreasing of necessity of topic corticoids usage to control outbreaks of light to moderate atopic dermatitis by using the correct emollients.

Conditions

  • Dermatitis, Atopic

Interventions

OTHER

Emollient - Cetaphil Advanced

Emollient - Cetaphil Advanced - to be applied twice a day for 20 weeks.

Sponsors & Collaborators

  • Galderma Brasil Ltda.

    lead INDUSTRY

Principal Investigators

  • Mario C Pires, MD · Complexo Hospitalar Padre Bento de Guarulhos

  • Izelda Costa, MD · Hospital Universitário de Brasília

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
2 Years
Max Age
10 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-12-31
Primary Completion
2010-09-30
Completion
2010-10-31

Countries

  • Brazil

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01063218 on ClinicalTrials.gov